Vanderbilt University Medical Center has announced it will stop performing gender-affirming plastic surgeries for adults, a move tied to operational limits, legal risks, and prior shifts in the hospital’s transgender care policies; this article examines the sequence of decisions, the legal context, and the practical consequences for patients and other hospitals weighing similar choices.
Vanderbilt’s decision to end adult gender-affirming plastic surgeries is significant because it was Tennessee’s only provider for those procedures. The hospital cited “operational limitations and lack of surgical coverage” in its statement, signaling a practical retreat rather than a sudden ideological reversal. For conservatives, this is evidence that institutions are recalibrating care plans in light of legal exposure and funding realities.
Hospitals nationwide are watching costs, liability, and regulatory pressures, and some are choosing to stop services that threaten Medicare and Medicaid funding or invite lawsuits. The debate has focused largely on minors, but adults who seek transition-related surgery are now affected as well. Vanderbilt’s move follows earlier steps that already scaled back services for younger patients and dismantled specialized programs.
Vanderbilt University Medical Center is discontinuing surgeries for transgender adults, the latest announcement for the Nashville hospital after a series of escalating concerns about its care for LGBTQ+ patients.
The hospital has a recent history of policy changes. In 2022, it stopped trans surgeries and puberty blockers for minors after the Tennessee legislature passed a restriction, and in 2025 it closed its LGBTQ health clinic. Those earlier shifts made the adult-surgery decision less surprising to observers who track institutional risk management. From a Republican perspective, the pattern looks like hospitals choosing prudence over taking exceptional clinical risks.
Vanderbilt confirmed the end of gender-affirming surgeries to the Scene with a written statement. These surgeries include orchiectomies, a testicular removal surgery, and subcutaneous mastectomies, the removal of breast tissue also known as “top surgery.”
“Due to operational limitations and lack of surgical coverage, Vanderbilt Health will cease providing gender-affirming plastic surgeries for adults,” said a VUMC spokesperson in an email Friday afternoon. “Vanderbilt Health continues to provide nonsurgical gender-affirming care for adults 19 years and older. Vanderbilt Health does not provide any gender-affirming care for patients younger than 19. We are in the process of contacting our patients regarding these changes.”
Legal developments have been a major factor. Hospitals that turn over medical records in response to state inquiries or face litigation risk may reassess programs that attract legal scrutiny. The Tennessee Attorney General’s earlier access to transgender patients’ records and subsequent legal disputes added pressure. Such precedents push administrators to weigh the costs of maintaining services that might provoke both lawsuits and political backlash.
Recent court decisions and high-profile verdicts are reshaping incentives for providers. A notable malpractice judgment involving a former minor who later sued her providers has become part of the public conversation and is cited by legal analysts as a possible catalyst for more suits. Conservatives view these outcomes as accountability for medical providers who moved too quickly or ignored long-term harms.
Cole believes the new guidance and recent legal victory could lead to a wave of additional lawsuits.
“These lawsuits are going to flood the court system and make it so that these doctors realize that there is a huge liability to these procedures and give them no other sane choice but to stop doing this to children,” she said.
Beyond litigation, financial considerations matter. Gender-affirming surgeries are not high-margin services for many hospitals, and the administrative burden of defending care choices can outweigh the benefits. When regulatory or political winds change, institutions may conclude the sensible route is to narrow their exposure rather than expand it. Vanderbilt’s step is likely to prompt similar internal reviews elsewhere.
Vanderbilt’s pivot also has human consequences: adults who planned surgeries must now seek alternatives, and communities that relied on a single regional provider could face travel burdens and treatment delays. The closure of a surgical program doesn’t eliminate demand, but it does create gaps in access and can reshape how care is delivered regionally. Policymakers and hospital boards are going to be hearing from patients, clinicians, and legal counsel as they chart next steps.
Ultimately, hospitals will continue to balance clinical autonomy with institutional risk, funding streams, and public accountability. For skeptics of expansive gender-affirming programs, Vanderbilt’s decision is a predictable response to mounting legal and operational realities. For others, it will raise concerns about access and patient choices. Either way, the landscape for transgender surgeries in America is changing, and more healthcare systems will be forced to make hard decisions about the services they provide.
Add comment